China to pass new foreign investment law in the wake of a trade war
By Akshay Kedari  Date: 2019-03-04

China to pass new foreign investment law in the wake of a trade war

China is said to maintain a highly clear policy with respect to its relationship with the United States.

China is reportedly on the verge of passing a novel foreign investment law in a bid to level the playing field for investors worldwide equipped with legal safeguards on technology transfer and IPR. Sources familiar with the knowledge of the matter claim that these were a part of some of the demands of President Donald Trump drawn up to end the trade war between both the countries.

Reportedly, China and the United States have been embroiled in an ugly trade war ever since the imposition of heavy tariffs on aluminum and steel items imported from China, by President Trump, since March last year. In consequence, China went on to impose heavy tariffs on American imports worth billions of dollars, the result of which sparked fears worldwide regarding a trade war.

In a bid to reach the end of the tunnel, China has scrambled up to hurriedly pass the new foreign investment law, that will apparently be submitted to the National People's Congress (NPC) – the top legislature, for a review. Speaking on the urgency of delivering the same, Zhang Yesui, spokesperson, NPC, was quoted stating that the interests of both the nations are severely interwoven and a U.S.-China relationship on the brink of conflict is not in anyone’s interest.

Elaborating further, Zhang asserts that China maintains a highly clear policy with respect to its relationship with the United States, that seemingly is not encompassed with conflicts, but is based on a no-confrontation, win-win, mutual respect cooperation.

Reliable reports affirm that major details of the deal are still largely unsettled, given that pivotal discussions are still on the go. However, according to The New York Times, both the nations seem to have agreed on a certain pact that may entail Beijing to make mammoth purchases of American energy and agricultural goods and also reduce specific barriers that have been restraining American firms from operating in China.

Also, it is being speculated that the U.S. may,  in turn, drop its tariffs on perhaps a minimum of USD 200 billion of the USD 250 billion worth of Chinese imports that are presently subject to American levies.

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

RADCOM introduces automated assurance solution for 5G technology
RADCOM introduces automated assurance solution for 5G technology
By Akshay Kedari

5G technology has been in the headlines for quite a while. Next-generation technology has the potential to transform almost every sector across the world. However, as 5G becomes reality, it has become imperative for service providers to prevent degra...

Sprout to expand wellness solutions lineup by acquiring Vivametrica
Sprout to expand wellness solutions lineup by acquiring Vivametrica
By Akshay Kedari

Sprout, a Canadian company that focuses on delivering innovative solutions for workplace wellbeing, has recently announced the acquisition of predictive health data analytics firm, Vivametrica. According to reliable sources, Sprout plans to enhance t...

Uber halts decision to shift APAC headquarters from Singapore
Uber halts decision to shift APAC headquarters from Singapore
By Akshay Kedari

Uber Technologies Inc., the American ride-hailing giant, has reportedly halted the company’s decision to relocate its Asia Pacific headquarters from Singapore to Hong Kong until December 2022. Sources cite that the company’s decision was...

PCI Pharma extends global clinical supply-chain services in Europe
PCI Pharma extends global clinical supply-chain services in Europe
By Akshay Kedari

U.S. based biopharmaceutical and pharma outsourcing services company, PCI Pharma services has reportedly announced that it reached a noteworthy milestone through the development of COE (Clinical Center of Excellence) in Berlin. According to credible...

Dassault to use Proxem’s AI solution to advance 3DEXPERIENCE platform
Dassault to use Proxem’s AI solution to advance 3DEXPERIENCE platform
By Akshay Kedari

French software company, Dassault Systèmes has recently revealed plans to enhance its 3DEXPERIENCE platform’s collaborative data science abilities, allowing customers to take advantage of their data patrimony by taking part in new v...